What Does the Research Say About Methylene Blue and Memory? A Review of the Human Clinical Studies
Short answer: A small number of human studies suggest methylene blue can modestly improve some aspects of memory. The best-known trial, published in Radiology in 2016, found that a single dose improved memory retrieval accuracy by about 7% in healthy adults and increased activity in brain regions tied to attention and memory. The evidence is promising but early: the studies are small, mostly short term, and not yet replicated at scale.
Why do researchers study methylene blue for memory?
Memory formation is energy intensive. Neurons need a steady ATP supply to strengthen synapses and consolidate new information. Methylene blue supports mitochondrial electron flow and increases the activity of cytochrome c oxidase, an enzyme closely linked to neuronal activity. That made it a logical candidate for memory research, first in animals and then in people.
What did animal studies find first?
Before human trials, rodent studies consistently showed that low-dose methylene blue improved memory retention. Work from the Gonzalez-Lima lab at the University of Texas at Austin found that low doses improved retention in maze and fear extinction tasks and increased cytochrome c oxidase activity in memory-related brain regions. These results set up the human research.
What human studies exist on methylene blue and memory?
|
Study |
Participants |
Design |
Main finding |
|
Rodriguez et al., Radiology, 2016 |
26 healthy adults |
Randomized, placebo-controlled, single oral dose, fMRI |
About 7% more correct responses during memory retrieval; more activity in insular, prefrontal, and parietal regions |
|
Telch et al., American Journal of Psychiatry, 2014 |
42 adults with claustrophobic fear |
Randomized, placebo-controlled, dose given after exposure therapy |
Better fear reduction at 1 month when sessions ended with low fear; improved contextual memory |
|
Alda et al., British Journal of Psychiatry, 2017 |
37 adults with bipolar disorder |
Randomized crossover, adjunct to standard treatment |
Reduced residual depression and anxiety symptoms; mood focused, not a memory trial |
|
TauRx LMTM trials (Gauthier et al., The Lancet, 2016, and later studies) |
Hundreds of adults with Alzheimer's disease |
Large phase 3 trials of a methylene blue derivative |
Did not meet primary endpoints as add-on therapy; later analyses remain debated |
What did the 2016 Radiology study actually show?
Researchers at UT Health San Antonio gave 26 healthy adults either a single oral dose of methylene blue or placebo, then scanned their brains with functional MRI during attention and short-term memory tasks. The methylene blue group showed:
- About 7% more correct answers during memory retrieval
- Greater activation in the bilateral insular cortex during the task
- Increased activity in prefrontal, parietal, and occipital regions linked to attention and working memory
It was the first randomized human study to connect methylene blue with measurable changes in both memory performance and brain activity.
What about memory in therapy settings?
The Telch study tested whether methylene blue could help people retain what they learned during exposure therapy. When therapy sessions ended with low fear, participants who took methylene blue afterward kept more of their improvement a month later. This suggests methylene blue may help consolidate new learning, though the effect depended on how the session went.
Does methylene blue help with Alzheimer's disease?
That question is not settled. A methylene blue derivative called LMTM (hydromethylthionine) was tested in large phase 3 Alzheimer's trials. The trials did not meet their main goals, and later analyses suggesting benefit in certain subgroups are still debated by researchers. Methylene blue is not an approved treatment for Alzheimer's disease or any form of dementia.
What are the limitations of the evidence?
- Small samples: the key cognitive trials enrolled dozens of people, not thousands
- Short timeframes: most measured effects after one or a few doses
- Specific populations: results in healthy young adults or therapy patients may not apply to everyone
- Research doses: trials used controlled pharmaceutical doses under supervision
- Few replications: no large independent trial has yet confirmed the 2016 memory results
FAQ
Is there clinical evidence that methylene blue improves memory?
There is early clinical evidence. A 2016 randomized trial in healthy adults found improved memory retrieval after a single dose, but larger and longer studies are needed.
How quickly did effects appear in the studies?
In the 2016 Radiology trial, effects were measured about one hour after a single dose.
Is methylene blue approved for memory or cognition?
No. In the United States, pharmaceutical methylene blue is FDA approved only for treating acquired methemoglobinemia.
Is it safe to try methylene blue for memory?
It can interact dangerously with SSRIs and other serotonergic medications and is not appropriate for people with G6PD deficiency. Talk to a doctor first.
References
- Rodriguez P, et al. Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. 2016;281(2):516-526.
- Telch MJ, et al. Effects of post-session administration of methylene blue on fear extinction and contextual memory in adults with claustrophobia. Am J Psychiatry. 2014;171(10):1091-1098.
- Alda M, et al. Methylene blue treatment for residual symptoms of bipolar disorder: randomised crossover study. Br J Psychiatry. 2017;210(1):54-60.
- Gauthier S, et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet. 2016;388(10062):2873-2884.
- Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Prog Neurobiol. 2012;96(1):32-45.
Where FocusBlu fits
The research on methylene blue is still developing, so choosing a product you can trust matters. FocusBlu uses USP-grade methylene blue that is third-party tested before purchase and formulates its 1% solution in small batches in Frisco, Texas. Five ingredients, all listed on the label: methylene blue (USP), purified water (USP), glycerin (USP), vitamin C, and stevia.
Learn more at focusblu.net.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Talk to your doctor before using methylene blue, especially if you take prescription medications.
